QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

22,576 signal articles · 98 in last 24h · 108,239 total before filter · latest 20m ago
98last 24h
2568last 7d
490● bullish (7d)
230● bearish (7d)
202publishers
AllMacro230Earnings1603M&A116Regulatory15Product11Analyst25
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearishshow all (incl. clickbait)
Investing.com10d agoneutral
TSMC is moving in on Intel’s turf; Why Intel is up anyway

Intel’s stock remains strong today despite a report from The Information indicating that Taiwan Semiconductor Manufacturing Co. (TSMC) is developing an "EMIB-like" advanced packaging technology, potentially challenging a key advantage for Intel’s Foundry business. However, the prospect of TSMC neutralizing this advantage hasn’t dented Intel’s share price, as the broader tech market is buoyed by massive AI spending commitments from companies like Microsoft and Meta. Here is why Intel’s stock is h

Bloomberg10d agoneutral
US GDP Growth Softens Despite Strong Consumer, Investment

(Bloomberg) -- The US economy grew at a weaker-than-expected pace in the second quarter, though a pickup in consumer spending and solid business investment signaled underlying strength. Most Read from BloombergUS Strikes Iran Again as Conflict Spreads Across Middle EastWarner Bros. Deal Collapse Would Cost the Ellisons $9.8 BillionStocks Fall as 30-Year Bond Yields Surge After Fed: Markets WrapMeta’s Zuckerberg Defends AI Bets to Skeptical InvestorsTrump Says US Will Strike Iran Hard as War Esca

Stocks Bounce Back From Fed Day Turmoil
Barrons.com10d agoneutral
Stocks Bounce Back From Fed Day Turmoil

Stocks kicked off Thursday’s trading session higher, reemerging from the carnage of Wednesday’s selloff. The S&P 500 was up 0.9%, while the Nasdaq Composite rose 1.6%. Rosenberg Research’s Dave Rosenberg described the moves as “a weak stock-market bound on shaky ground,” nodding to the major averages’ “precarious technical positions,” yesterday’s rise in bond yields, and oil price spikes.

Sanofi Q2 Earnings Call Highlights
MarketBeat10d agoneutral
Sanofi Q2 Earnings Call Highlights

Sanofi (NASDAQ:SNY) raised its 2026 outlook after reporting double-digit second-quarter sales and earnings growth, driven by Dupixent, recently launched medicines and cost discipline. The company also increased its 2030 sales ambition for Dupixent to approximately €25 billion while outlining an ongo